Download PDF
Aktuelle Rheumatologie 2007; 32(4): 202-207
DOI: 10.1055/s-2007-963223
Originalarbeit

© Georg Thieme Verlag KG Stuttgart · New York

Entzündlich-rheumatische Erkrankungen und kardiovaskuläres Risiko: ernährungsmedizinische Aspekte

Inflammatory Rheumatic Diseases and Cardiovascular Risks: Aspects of Nutritional MedicineH.-E Langer1
  • 1n/a, Schwerpunkt für Rheumatologie, klinische Immunologie und Osteologie am Evangelischen Krankenhaus Düsseldorf
Further Information

Publication History

Publication Date:
04 September 2007 (online)

Also available at
   Permissions and Reprints
Preview

Zusammenfassung

Chronische Entzündung ist ein unabhängiger Risikofaktor für kardiovaskuläre Komplikationen bei rheumatischen Erkrankungen. Die erhöhte Mortalität kann durch eine effektive Krankheitskontrolle reduziert werden. Ernährungsmedizinische Ansätze zielen auf die Prävention und Therapie traditioneller kardiovaskulärer Risikofaktoren wie arterielle Hypertonie, Adipositas oder Hyperlipoproteinämie, können aber auch unmittelbar zur Senkung der Entzündungsaktivität beitragen.

Abstract

Chronic inflammation is an independent risk factor for cardiovascular comorbidity in rheumatic diseases. Effective disease-modifying drugs reduce this increased mortality. The targets of nutritional interventions are not only the traditional risk factors such as hypertension, obesity or hyperlipoproteinemia but also to achieve a reduction of the inflammation.

Schlüsselwörter

Entzündlich-rheumatische Erkrankungen - rheumatoide Arthritis - kardiovaskuläres Risiko - Komorbidität - Mortalität - Ernährung - Ernährungsmedizin - Diät

Key words

rheumatic diseases - rheumatoid arthritis - cardiovascular risks - comorbidity - mortality - nutrition - nutritional medicine - diet

Literatur

  • 1 Isomäki H A, Mutru O, Koota K. Death rate and causes of death in patients with rheumatoid arthritis.  Scand J Rheumatol. 1975;  4 205-208
    Search in Google Scholar
  • 2 Prior P, Symmons D P, Scott D L. et al . Cause of death in rheumatoid arthritis.  Br J Rheumatol. 1984;  23 92-99
    Search in Google Scholar
  • 3 Mutru O, Laakso M, Isomaki H. et al . Ten year mortality and causes of death in patients with rheumatoid arthritis.  Br Med J (Clin Res Ed). 1985;  290 1797-1799
    Search in Google Scholar
  • 4 Mitchell D M, Spitz P W, Young D Y. et al . Survival, prognosis, and causes of death in rheumatoid arthritis.  Arthritis Rheum. 1986;  29 706-714
    Search in Google Scholar
  • 5 Pinals R S. Survival in rheumatoid arthritis.  Arthritis Rheum. 1987;  30 473-475
    Search in Google Scholar
  • 6 Wolfe F, Mitchell D M, Sibley J T. et al . The mortality of rheumatoid arthritis.  Arthritis Rheum. 1994;  37 481-94
    Search in Google Scholar
  • 7 Riise T, Jacobsen B K, Gran J T. et al . Total mortality is increased in rheumatoid arthritis. A 17-year prospective study.  Clin Rheumatol. 2001;  20 123-127
    Search in Google Scholar
  • 8 Watson D J, Rhodes T, Guess H A. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database.  J Rheumatol. 2003;  30 1196-1202
    Search in Google Scholar
  • 9 Goodson N J, Wiles N J, Lunt M. et al . Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.  Arthritis Rheum. 2002;  46 2010-2019
    Search in Google Scholar
  • 10 Solomon D H, Karlson E W, Rimm E B. et al . Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.  Circulation. 2003;  107 1303-1307
    Search in Google Scholar
  • 11 del Rincon I, Williams K, Stern M P. et al . High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.  Arthritis Rheum. 2001;  44 2737-2745
    Search in Google Scholar
  • 12 Gabriel S E, Crowson C S, Kremers H M. et al . Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.  Arthritis Rheum. 2003;  48 54-58
    Search in Google Scholar
  • 13 Maradit-Kremers H, Crowson C S, Nicola P J. et al . Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.  Arthritis Rheum. 2005;  52 402-411
    Search in Google Scholar
  • 14 Soubrier M, Zerkak D, Dougados M. Indications for Lowering LDL Cholesterol in Rheumatoid Arthritis: An Unrecognized Problem.  J Rheumatol. 2006;  33 1766-1769
    Search in Google Scholar
  • 15 Bessant R, Duncan R, Ambler G. et al . Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.  Arthritis Rheum. 2006;  55 892-899
    Search in Google Scholar
  • 16 De Leeuw K, Freire B, Smit A J. et al . Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus.  Lupus. 2006;  15 675-682
    Search in Google Scholar
  • 17 Maksimovicz-McKinnon K, Magder L S, Petri M. Predictors of Carotid Atherosclerosis in Systemic Lupus Erythematosus.  J Rheumatol. 2006;  33 2458-2463
    Search in Google Scholar
  • 18 De Leeuw K, Sanders J S, Stegeman C. et al . Accelerated atherosclerosis in patients with Wegener’s granulomatosis.  Annals of the Rheumatic Diseases. 2005;  64 753-759
    Search in Google Scholar
  • 19 Han C, Robinson D W, Hackett M V. et al . Cardiovascular Disease and Risk Factors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.  J Rheumatol. 2006;  33 2167-2172
    Search in Google Scholar
  • 20 Solomon D H. et al . Patterns of cardiovascular risk In rheumatoid arthritis.  Ann Rheum Dis. 2006;  65 1608-1612
    Search in Google Scholar
  • 21 Yalamanchili Jr K, Aronow W S, Kilaru R. et al . Coronary Artery Disease Is More Severe in Older Persons With Rheumatoid Arthritis Than in Older Persons Without Rheumatoid Arthritis.  Cardiology in Review. 2006;  14 55-56
    Search in Google Scholar
  • 22 Esdaile J M, Abrahamowicz M, Grodzicky T. et al . Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.  Arthritis Rheum. 2001;  44 (10) 2331-2337
    Search in Google Scholar
  • 23 Björnådal L, Brandt L, Klareskog L. et al . Impact of parental history on patients’ cardiovascular mortality in rheumatoid arthritis.  Annals of the Rheumatic Diseases. 2006;  65 741-745
    Search in Google Scholar
  • 24 Wallberg-Jonsson S. et al . Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.  J Rheumatol. 1999;  26 2562-2571
    Search in Google Scholar
  • 25 Liang K P. et al . Mayo Clinic and Mayo Graduate School of Medicine, Rochester, Minnesota: Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations.  Arthritis Rheum. 2006;  54 (2) 642-648
    Search in Google Scholar
  • 26 Turesson C, McClelland R L, Christianson T J. et al . Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis.  Ann Rheum Dis. 2007;  66 70-75
    Search in Google Scholar
  • 27 Roman M J, Moeller E, Davis A. et al . Preclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis.  Annals of Internal Medicine. 2006;  144 249-256
    Search in Google Scholar
  • 28 del Rincon I, Freeman G L, Haas R W. et al . Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis.  Arthritis Rheum. 2005;  52 (11) 3413-3423
    Search in Google Scholar
  • 29 Del Rincon I, O’leary D H, Freeman G L. et al . Acceleration of atherosclerosis during the course of rheumatoid arthritis.  Atherosclerosis. 2006;  9 Epub ahead of print
    Search in Google Scholar
  • 30 Boers M, Nurmohamed M T, Doelman C J. et al . Influence of glucocorticoid and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.  Ann Rheum Dis. 2003;  62 842-845
    Search in Google Scholar
  • 31 Situnayake R, Kitas G. Dyslipidemia and rheumatoid arthritis.  Ann Rheum Dis. 1997;  56 341-342
    Search in Google Scholar
  • 32 Park Y B, Lee S K, Lee W K. et al . Lipid profiles in untreated patients with rheumatoid arthritis.  J Rheumatol. 1999;  26 1701-1704
    Search in Google Scholar
  • 33 Lorber M, Aviram M, Linn S. et al . Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis.  r J Rheumatol. 1985;  24 250-255
    Search in Google Scholar
  • 34 Frati E, Castagna M L, Bacarelli M R. et al . Plasma levels of apolipoprotein and HDL-cholesterol in patients with rheumatoid arthritis.  Boll Soc Ital Biol Sper. 1984;  60 1791-1796
    Search in Google Scholar
  • 35 Lazarevic M B, Vitic J, Mladenovic V. et al . Dyslipoproteinemia in the course of active rheumatoid arthritis.  Semin Arthritis Rheum. 1992;  22 172-178
    Search in Google Scholar
  • 36 Georgiadis A N, Papavasiliou E C, Lourida E S. et al . Atherogenic Lipid Profile is a Feature Characteristic of Patients With Early Rheumatoid Arthritis: Effect of Early Treatment - A Prospective, Controlled Study.  Arthritis Res Ther. 2006;  8 (3): R82. Epub 2006 Apr 28 , http://arthritis-research.com/content/8/3/R82
    Search in Google Scholar
  • 37 Halm V P, Nielen M M, Nurmohamed M T. et al . Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis.  Annals of the Rheumatic Diseases. 2007;  66 184-188
    Search in Google Scholar
  • 38 McCarey D W, McInnes I B, Madhok van R. et al . Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomized, placebo-controlled trial.  Lancet. 2004;  363 2015-1021
    Search in Google Scholar
  • 39 Riboldi P, Gerosa M, Meroni P L. Statins and autoimmune diseases.  Lupus. 2005;  14 765-768
    Search in Google Scholar
  • 40 Penney C J. Statins in rheumatology.  J Rheumatol. 2005;  32 17-19
    Search in Google Scholar
  • 41 Nagashima T, Okazaki H, Yudoh K. et al . Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: A potential therapeutic approach to rheumatoid arthritis.  Arthritis Rheum. 2006;  54 (2) 579-586
    Search in Google Scholar
  • 42 Xu H, Liu P, Liang L. et al . RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin.  Arthritis Rheum. 2006;  54 (11) 3441-3451
    Search in Google Scholar
  • 43 Choi H K, Hernan M A, Seeger J D. et al . Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.  Lancet. 2002;  359 1173-1177
    Search in Google Scholar
  • 44 Halm V P, Nurmohamed M T, Twisk J WR. et al . Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.  Research & Therapy. 2006;  8 R151
    Search in Google Scholar
  • 45 Jacobsson L T, Turesson van C, Gülfe A. et al . Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.  J Rheumatol. 2005;  32 1213-1218
    Search in Google Scholar
  • 46 Jacobsson L T, Turesson C, Nilsson J A. et al . Treatment with TNF-blockers and mortality risk in patients with rheumatoid arthritis.  Ann Rheum Dis. 2006;  11 Epub ahead of print , http://ard.bmj.com/cgi/content/abstract/ard.2006.062497v1
    Search in Google Scholar
  • 47 Bilsborough W, Keen H, Taylor A. et al . Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis.  Rheumatol Int. 2006;  26 (12) 1125-1131
    Search in Google Scholar
  • 48 Dixon W G, Symmons D PM. What effects might anti-TNF-alpha-therapy be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNF-alpha in cardiovascular pathophysiology.  Ann Rheum Dis. 2007;  24 Epub ahead of print , http://ard.bmj.com/cgi/content/abstract/ard.2006.063867v1
    Search in Google Scholar
  • 49 Boers M, Nurmohamed M T, Doelman C J. et al . Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.  Ann Rheum Dis. 2003;  62 842-845
    Search in Google Scholar
  • 50 Spanakis E, Sidiropoulos P, Papadakis J. et al . Modest But Sustained Increase of Serum High Density Lipoprotein Cholesterol Levels in Patients with Inflammatory Arthritides Treated with Infliximab.  J Rheumatol. 2006;  33 (12) 2440-2446
    Search in Google Scholar
  • 51 Kiortsis D N, Mavridis A K, Filippatos T D. et al . Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.  J Rheumatol. 2006;  33 (5) 921-923
    Search in Google Scholar
  • 52 Popa C, Netea M G, Radstake T. et al . Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.  Ann Rheum Dis. 2005;  64 303-305
    Search in Google Scholar
  • 53 Popa C, Hoogen F H, Radstake T R. et al . Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.  Ann Rheum Dis. Published Online First: 1 May 2007;  , http://ard.bmj.com/cgi/content/abstract/ard.2006.066191v1
    Search in Google Scholar
  • 54 Adam van der O, Beringer C, Kless T. et al . Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis.  Rheumatol Int. 2003;  23 27-36
    Search in Google Scholar
  • 55 Keysser G. Klinische Studien entzündlich-rheumatischer Erkrankungen in der Ernährungsmedizin.  Akt Rheumatol. 2007;  32 194-199
    Search in Google Scholar
  • 56 Sundström B, Stålnacke K, Hagfors L. et al . Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis.  Scandinavian Journal of Rheumatology. 2006;  35 359-362
    Search in Google Scholar
  • 57 Cleland L G, Caughey G E, James M J. et al . Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.  J Rheumatol. 2006;  33 1973-1979
    Search in Google Scholar
  • 58 GISSI-Prevenzione Investigators . Dietary suplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.  Lancet. 1999;  354 447-455
    Search in Google Scholar
  • 59 Pham T, Gossec L, Constantin A. et al . Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion.  Joint Bone Spine. 2006;  73 379-387
    Search in Google Scholar
  • 60 Chung C P, Oeser A, Avalos I. et al . Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis.  Arthritis Res Ther. 2006;  8 R186
    Search in Google Scholar
  • 61 Wilson P WF, D’Agostino R B, Levy D. et al . Prediction of coronary heart disease using risk factor categories.  Circulation. 1998;  97 1837-1847
    Search in Google Scholar

1 Der Framingham-Score [60] ermöglicht auch bei Patienten mit einer rheumatoiden Arthritis eine Abschätzung des kardiovaskulären Risikos [61]. Eine Anleitung für die Kalkulation steht online zur Verfügung [62].

Priv. Doz. Dr. med. Hans-Eckhard Langer

Schwerpunkt für Rheumatologie, klinische Immunologie und Osteologie am Evangelischen Krankenhaus Düsseldorf

Fürstenwall 99

40217 Düsseldorf

Phone: ++49/2 11/5 20 66 60

Fax: ++49/2 11/9 94 44 80

Email: dr.langer@rheuma-online.de